Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America (2021)
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidades: FMRP, FM
Subjects: CÉLULAS-TRONCO, ANTÍGENOS, LINFOMA, ONCOLOGIA, AMÉRICA LATINA
ABNT
CUNHA, Renato Luiz Guerino et al. Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-154217. Acesso em: 05 nov. 2024. , 2021APA
Cunha, R. L. G., Clé, D. V., Palma, L. C., Donadel, C. D., Oliveira, L., Terra, P. O. da C., et al. (2021). Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-154217NLM
Cunha RLG, Clé DV, Palma LC, Donadel CD, Oliveira L, Terra PO da C, Costa TC de M, Dias JBE, Pieroni F, Stracieri ABPL, Silveira CRF, Puga ML, Martins AP, Caruso SR, Souza LEB de, Fantacini DMC, Barboza LMD, Giuberti MFL, Pereira G de C, Fernandes TR, Bolzoni RMF, Vieira ACJ, Palma PVB, Basile-Filho A, Chahud F, Prado Júnior B de PA, Orellana MD, Santis GCD, Rego EM, Calado RT, Covas DT. Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America [Internet]. Blood. 2021 ; 138 4843.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1182/blood-2021-154217Vancouver
Cunha RLG, Clé DV, Palma LC, Donadel CD, Oliveira L, Terra PO da C, Costa TC de M, Dias JBE, Pieroni F, Stracieri ABPL, Silveira CRF, Puga ML, Martins AP, Caruso SR, Souza LEB de, Fantacini DMC, Barboza LMD, Giuberti MFL, Pereira G de C, Fernandes TR, Bolzoni RMF, Vieira ACJ, Palma PVB, Basile-Filho A, Chahud F, Prado Júnior B de PA, Orellana MD, Santis GCD, Rego EM, Calado RT, Covas DT. Viability of Chimeric Antigen Receptor T Cell Therapy in Latin America [Internet]. Blood. 2021 ; 138 4843.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1182/blood-2021-154217